Amos D. Korczyn

Amos D. Korczyn's AcademicInfluence.com Rankings

Amos D. Korczyn

Medical

#988

World Rank

#1271

Historical Rank

Neurology

#91

World Rank

#141

Historical Rank

medical Degrees

Amos D. Korczyn

Philosophy

#3435

World Rank

#5557

Historical Rank

Logic

#1159

World Rank

#1838

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Amos D. Korczyn's Degrees

Masters Medicine Tel Aviv University
PhD Neurology Tel Aviv University

Why Is Amos D. Korczyn Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Amos D. Korczyn's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Diagnosis and management of dementia with Lewy bodies (2005) (3346)
Vascular dementia (1993) (2657)
Clinical diagnostic criteria for dementia associated with Parkinson's disease (2007) (2413)
Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force (2007) (918)
Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1 (2013) (583)
X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment (2008) (386)
MECHANISM OF PLACEBO ANALGESIA (1978) (383)
Post-stroke dementia – a comprehensive review (2017) (383)
Freezing of gait in patients with advanced Parkinson's disease (2001) (348)
Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1 (2008) (315)
Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy (2012) (303)
The amyloid cascade hypothesis (2008) (293)
Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease (2011) (271)
High b‐value q‐space analyzed diffusion‐weighted MRI: Application to multiple sclerosis (2002) (257)
The value of muscle exercise in patients with amyotrophic lateral sclerosis (2001) (251)
Ten‐year follow‐up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa (2007) (249)
PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome. (2012) (228)
Subjective memory complaints in elders: depression, anxiety, or cognitive decline? (2013) (227)
ApoE4: an emerging therapeutic target for Alzheimer’s disease (2019) (227)
Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease (2000) (210)
A homozygous mutation in human PRICKLE1 causes an autosomal-recessive progressive myoclonus epilepsy-ataxia syndrome. (2008) (204)
Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study (2018) (204)
Rotigotine transdermal patch in early Parkinson's disease: A randomized, double‐blind, controlled study versus placebo and ropinirole (2007) (200)
Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects (2017) (188)
Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes (1999) (188)
Mixed Dementia—the Most Common Cause of Dementia (2002) (187)
Mutation in codon 200 of scrapie amyloid precursor gene linked to Creutzfeldt-Jakob disease in Sephardic Jews of Libyan and non-Libyan origin (1990) (185)
Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease? (2018) (183)
Ropinirole in the treatment of early Parkinson's disease: A 6‐month interim report of a 5‐year levodopa‐controlled study (1998) (180)
Epilepsy and mental retardation limited to females: an under-recognized disorder. (2008) (180)
Auditory hallucinations in Parkinson’s disease (1998) (179)
Ultra-rare genetic variation in the epilepsies: a whole-exome sequencing study of 17,606 individuals (2019) (176)
Computer-Based, Personalized Cognitive Training versus Classical Computer Games: A Randomized Double-Blind Prospective Trial of Cognitive Stimulation (2011) (169)
Rasagiline Mesylate, a New Mao-B Inhibitor for the Treatment of Parkinson's Disease: A Double-Blind Study as Adjunctive Therapy to Levodopa (2000) (168)
[Sleep disturbances]. (2017) (166)
Consensus statement for diagnosis of subcortical small vessel disease (2016) (163)
Development of dyskinesias in a 5‐year trial of ropinirole and L‐dopa (2006) (159)
Acute infection as a risk factor for ischemic stroke. (1996) (158)
Kinematic analysis of upper limb trajectories in Parkinson's disease (1992) (144)
Genetic Architecture of Idiopathic Generalized Epilepsy: Clinical Genetic Analysis of 55 Multiplex Families (2004) (141)
Association between ocular pressure and certain health parameters. (1984) (141)
The Vascular Impairment of Cognition Classification Consensus Study (2017) (140)
Sexual Dysfunction in Parkinson's Disease (2004) (139)
The VITATOPS (Vitamins to Prevent Stroke) Trial: Rationale and Design of an International, Large, Simple, Randomised Trial of Homocysteine-Lowering Multivitamin Therapy in Patients with Recent Transient Ischaemic Attack or Stroke (2002) (138)
[Vagus nerve stimulation for partial seizures]. (1995) (137)
Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson's disease (1992) (135)
Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community. (2003) (135)
Handwriting process variables discriminating mild Alzheimer's disease and mild cognitive impairment. (2006) (134)
Galantamine treatment of vascular dementia (2007) (133)
ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia. (1998) (133)
Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: A 6‐month interim report of a 3‐year study (1998) (126)
Female sexuality in multiple sclerosis: the multidimensional nature of the problem and the intervention (2010) (125)
The oculopharyngeal muscular dystrophy locus maps to the region of the cardiac α and β myosin heavy chain genes on chromosome 14q11.2−q13 (1995) (123)
Autonomic impairment in amyotrophic lateral sclerosis (2005) (123)
Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model. (1997) (120)
DEPRENYL IN PARKINSON'S DISEASE (1982) (120)
Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer (2003) (120)
EEG in demented and non‐demented parkinsonian patients (1988) (118)
Phenytoin pharmacokinetics in catamenial epilepsy (1984) (118)
APOE genotype is a major predictor of long-term progression of disability in MS (2001) (117)
EEG frequency analysis in demented and nondemented parkinsonian patients. (1994) (117)
Psychological stress as risk factor for exacerbations in multiple sclerosis (1993) (112)
The pupillary effects of opioids. (1983) (112)
Vascular parkinsonism—characteristics, pathogenesis and treatment (2015) (112)
Use of the Virtual Action Planning Supermarket for the Diagnosis of Mild Cognitive Impairment (2009) (112)
Efficacy and safety of a once‐daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial (2010) (110)
Life-long history of injuries related to seizures (1999) (108)
Early onset dementia: clinical and social aspects (2009) (104)
Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies (2019) (102)
Antiparkinsonian medication is not a risk factor for the development of hallucinations in Parkinson’s disease (2004) (99)
The risk of developing Creutzfeldt‐Jakob disease in subjects with the PRNP gene codon 200 point mutation (1994) (96)
Smoking and tea consumption delay onset of Parkinson's disease. (2009) (95)
Depression and dementia (2009) (94)
Presenile dementia in Israel. (1986) (94)
Homozygotes for oculopharyngeal muscular dystrophy have a severe form of the disease (1999) (91)
The role of neuronal nicotinic acetylcholine receptor subunits in autonomic ganglia: lessons from knockout mice (2002) (90)
Improvement of parkinsonian features correlate with high plasma levodopa values after broad bean (Vicia faba) consumption. (1992) (89)
The Tel Aviv Stroke Registry. 3600 consecutive patients. (1996) (89)
Clinical heterogeneity and unusual presentations of Creutzfeldt-Jakob disease in Jewish patients with the PRNP codon 200 mutation. (1993) (88)
LGI1 mutations in temporal lobe epilepsies (2004) (87)
Association of APOE ε4 allele with survival in amyotrophic lateral sclerosis (2001) (87)
Ancestral origins and worldwide distribution of the PRNP 200K mutation causing familial Creutzfeldt-Jakob disease. (1999) (87)
Inheritance of idiopathic torsion dystonia among Jews. (1984) (85)
Genetic epilepsy with febrile seizures plus (2017) (85)
Nonsteroidal anti-inflammatory drugs exposure and the central nervous system. (2014) (85)
Familial neonatal seizures in 36 families: Clinical and genetic features correlate with outcome (2015) (85)
Rivastigmine (Exelon) for dementia in patients with Parkinson's disease (2003) (84)
Autonomic function in mice lacking α5 neuronal nicotinic acetylcholine receptor subunit (2002) (84)
Evaluation of the Short Parkinson's Evaluation Scale: a new friendly scale for the evaluation of Parkinson's disease in clinical drug trials. (1997) (83)
Mild cognitive impairment: Conceptual, assessment, ethical, and social issues (2008) (81)
Prevalence of Alzheimer's type dementia in an elderly Arab population (2001) (81)
Idiopathic intracranial hypertension (2004) (81)
Towards the concept of disease-modifier in post-stroke or vascular cognitive impairment: a consensus report (2017) (80)
Mental and Behavioral Dysfunction in Movement Disorders (2003) (80)
Autonomic nervous system disturbances in Parkinson's disease. (1990) (80)
Practice parameters and technology assessments: What they are, what they are not, and why you should care (2009) (79)
Phosphatidylserine Containing ω–3 Fatty Acids May Improve Memory Abilities in Non-Demented Elderly with Memory Complaints: A Double-Blind Placebo-Controlled Trial (2010) (77)
Hyperactivity in a mouse model of the antiphospholipid syndrome (2001) (77)
The prevention of the dementia epidemic (2007) (77)
Low-dose Clozapine in the Treatment of Levodopa-Induced Mental Disturbances in Parkinson's Disease (1995) (76)
Bell's palsy and diabetes mellitus. (1971) (75)
[Muscle diseases]. (1974) (74)
Behavioral and cognitive deficits occur only after prolonged exposure of mice to antiphospholipid antibodies (2002) (73)
Clinical characteristics of neuroleptic-induced parkinsonism (2001) (73)
Impact of first-ever mild stroke on participation at 3 and 6 month post-event: the TABASCO study (2015) (72)
Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus report (2017) (72)
Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia. (2000) (71)
What are the correlates of cognition and participation to return to work after first ever mild stroke? (2015) (71)
M1 Agonists for the Treatment of Alzheimer's Disease. (1996) (70)
Quality of sexual life in Parkinson's disease. (2002) (70)
A History of Migraine Is Not A Risk Factor to Develop an Ischemic Stroke in the Elderly (2001) (68)
Editorial comments (2011) (68)
Double-blind comparison of cabergoline and bromocriptine in Parkinson's disease patients with motor fluctuations (1996) (68)
Management of mild cognitive impairment (MCI): The need for national and international guidelines (2020) (67)
Dementia and Antiphospholipid Antibodies (2000) (67)
Fatal insomnia in a case of familial Creutzfeldt-Jakob disease with the codon 200Lys mutation (1996) (67)
The diabetic brain and cognition (2017) (67)
Sympathetic skin response (1993) (65)
The effects of APOE genotype on age at onset and progression of neurodegenerative diseases (2001) (65)
Disorders of the Oral Cavity in Parkinson's Disease and Parkinsonian Syndromes (2015) (64)
Hallucinations in Parkinson's disease (2001) (63)
Demyelinating peripheral neuropathy in Creutzfeldt–Jakob disease (1992) (63)
White matter changes in multiple sclerosis: correlation of q-space diffusion MRI and 1H MRS. (2005) (62)
Drug treatment of Parkinson's disease (2004) (62)
Cognitive Decline After Stroke: Relation to Inflammatory Biomarkers and Hippocampal Volume (2013) (61)
Sympathetic pupillary tone in old age. (1976) (61)
EEG changes during long-term treatment with donepezil in Alzheimer's disease patients (2001) (61)
Gender differences in lay persons' beliefs and knowledge about Alzheimer's disease (AD): a national representative study of Israeli adults. (2013) (59)
Preliminary Observations on APOE ϵ4 Allele and Progression of Disability in Multiple Sclerosis (1999) (59)
Lupus anticoagulant and late onset seizures (1989) (58)
Translational research on reserve against neurodegenerative disease: consensus report of the International Conference on Cognitive Reserve in the Dementias and the Alzheimer’s Association Reserve, Resilience and Protective Factors Professional Interest Area working groups (2019) (58)
Sound lateralization and interaural discrimination. Effects of brainstem infarcts and multiple sclerosis lesions (2000) (58)
Sequence Variants in SLC6A3, DRD2, and BDNF Genes and Time to Levodopa-Induced Dyskinesias in Parkinson’s Disease (2014) (58)
The nigrostriatal dopaminergic system in familial early onset parkinsonism with parkin mutations (2001) (57)
Stress and epilepsy: the Gulf war experience (1994) (57)
Apolipoprotein E4 in Parkinson Disease and Dementia: New Data and Meta‐Analysis of Published Studies (1998) (56)
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2013) (56)
Kinematic properties of upper limb trajectories in idiopathic torsion dystonia. (1995) (56)
Kinematic properties of upper-limb trajectories in Parkinson's disease and idiopathic torsion dystonia. (1990) (55)
Complex segregation analysis of dystonia pedigrees suggests autosomal dominant inheritance (1990) (55)
Stroke in Hospitalized Patients: Are There Special Risk Factors? (2002) (55)
Release of platelet 5-hydroxytryptamine by plasma taken from patients during and between migraine attacks (1976) (55)
Microembolism, silent brain infarcts and dementia (2012) (54)
Hypersensitivity vasculitis and systemic lupus erythematosus induced by anticonvulsants. (1993) (54)
Genetic and environmental risk factors for alzheimer’s disease in israeli arabs (2002) (53)
The underdiagnosis of the vascular contribution to dementia (2005) (53)
High b value q-space-analyzed diffusion MRI in vascular dementia: A preliminary study (2002) (53)
An updated diagnostic approach to subtype definition of vascular parkinsonism - Recommendations from an expert working group. (2017) (53)
Ropinirole in Gilles de la Tourette syndrome (2004) (53)
Fasting Headache, Weight Loss, and Dehydration (1999) (52)
Antibodies to Cholinergic Neurons in Alzheimer's Disease (1988) (52)
Epidemiology and inheritance of oculopharyngeal muscular dystrophy in Israel (1997) (52)
Effects of rivastigmine on the quantitative EEG in demented Parkinsonian patients (2003) (52)
A new clinical and molecular form of Unverricht-Lundborg disease localized by homozygosity mapping. (2005) (51)
Hyperactivity in rats following postnatal anoxia (1983) (51)
Medical Cannabis in Parkinson Disease: Real-Life Patients' Experience (2017) (51)
Prevalence and clinical features of dementia associated with the antiphospholipid syndrome and circulating anticoagulants (2002) (51)
Clinical features of oculopharyngeal muscular dystrophy among Bukhara Jews (1993) (50)
Myoclonus epilepsy and ataxia due to KCNC1 mutation: Analysis of 20 cases and K+ channel properties (2017) (50)
Brainstem lesions and click lateralization in patients with multiple sclerosis (1995) (50)
Parkinsonism in patients with lucanar infarcts of the basal ganglia. (1995) (49)
Predictors for Poststroke Outcomes: The Tel Aviv Brain Acute Stroke Cohort (TABASCO) Study Protocol (2012) (48)
Mechanical ventilation in stroke patients--is it worthwhile? (1996) (48)
The complex nosological concept of vascular dementia (2002) (48)
Deficiency of nicotinic acetylcholine receptor beta 4 subunit causes autonomic cardiac and intestinal dysfunction. (2003) (47)
Prediction of binaural click lateralization by brainstem auditory evoked potentials (1990) (47)
Neuropsychological evaluation of late-onset post-radiotherapy encephalopathy: a comparison with vascular dementia (2005) (47)
The effect of cigarette smoking, tea, and coffee consumption on the progression of Parkinson's disease. (2007) (47)
Incidence of dementia in patients with subjective memory complaints (2005) (46)
Association of APOE epsilon4 allele with survival in amyotrophic lateral sclerosis. (2001) (46)
Periodic lateralized epileptiform discharges (PLEDs) following stroke are associated with metabolic abnormalities. (1997) (46)
Gender effect on time to levodopa-induced dyskinesias (2011) (45)
The A677V methylenetetrahydrofolate reductase gene polymorphism and carotid atherosclerosis. (1999) (45)
Disorders of excessive daytime sleepiness—an update (1998) (45)
Why Have We Failed to Cure Alzheimer's Disease? (2014) (45)
Denervation, supersensitivity and muscarinic receptors in the cat iris. (1979) (45)
The oculopharyngeal muscular dystrophy locus maps to the region of the cardiac alpha and beta myosin heavy chain genes on chromosome 14q11.2-q13. (1995) (45)
Occurrence of seizures in association with work‐related stress in young male army recruits (2008) (44)
Vascular dementia (2012) (44)
Broad bean (Vicia faba) consumption and Parkinson's disease. (1993) (44)
Oculopharyngeal MD among Bukhara Jews is due to a founder (GCG)9 mutation in the PABP2 gene (2000) (44)
Parkinson's disease: Before the motor symptoms and beyond (2010) (44)
Broad Phenotypic Heterogeneity due to a Novel SCN1A Mutation in a Family With Genetic Epilepsy With Febrile Seizures Plus (2014) (44)
Creutzfeldt‐Jakob disease profile in patients homozygous for the PRNP E200K mutation (2000) (43)
BELL'S PALSY AND PREGNANCY (1971) (43)
Intravascular malignant lymphomatosis: a cause of subacute dementia. (1995) (43)
Mechanisms of syncope in glossopharyngeal neuralgia. (1986) (43)
Only White Matter Hyperintensities Predicts Post-Stroke Cognitive Performances Among Cerebral Small Vessel Disease Markers: Results from the TABASCO Study. (2017) (42)
Cerebral amyloid angiopathy impact on endothelium (2012) (42)
Basal ganglia lacunes and parkinsonism. (1994) (42)
ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin) (2017) (41)
APOE-ε4 in Patients with Alzheimer Disease and Vascular Dementia (1996) (41)
Naproxen Sodium Versus Ergotamine Tartrate in the Treatment of Acute Migraine Attacks (1992) (41)
Mutation of the nuclear lamin gene LMNB2 in progressive myoclonus epilepsy with early ataxia. (2015) (41)
Phosphatidylserine containing Omega-3 fatty acids may improve memory abilities in nondemented elderly with memory complaints: A double-blind placebo-controlled trial (2010) (41)
Torsion dystonia in israel (1980) (41)
Plasma homocysteine, vitamin B12 and folate in Alzheimer's patients and healthy Arabs in Israel (2004) (40)
Effects of a single intravenous dose of scopolamine on the quantitative EEG in Alzheimer's disease patients and age-matched controls. (1994) (40)
Quantitative anal sphincter EMG in multisystem atrophy and 100 controls (2001) (40)
F-wave characteristics following acute and chronic upper motor neuron lesions. (1993) (40)
Diabetes and the brain: issues and unmet needs (2014) (40)
Placebo responses in randomized trials of antiepileptic drugs (2010) (40)
Muscle hypertrophy with neuropathy (1978) (40)
Increased thrombin inhibition in experimental autoimmune encephalomyelitis (2005) (40)
Type 2 Diabetes Mellitus and Impaired Renal Function Are Associated With Brain Alterations and Poststroke Cognitive Decline (2017) (40)
Epilepsy, cognition, and neuropsychiatry (Epilepsy, Brain, and Mind, part 2) (2013) (40)
Prefrontal Compensatory Mechanism May Enable Normal Semantic Memory Performance in Mild Cognitive Impairment (MCI) (2010) (39)
Re: The apolipoprotein E epsilon4 allele increases the risk of drug-induced hallucinations in Parkinson's disease. (2000) (39)
Can Biomarkers Help the Early Diagnosis of Parkinson’s Disease? (2017) (39)
Commentary on “Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.” (2011) (38)
Hemodynamic effects of liquid food ingestion in mid-thoracic paraplegia: is supine postprandial hypotension related to thoracic spinal cord damage? (2007) (38)
The ocular effects of cannabinoids. (1980) (38)
The diagnostic aid of routine EEG findings in patients presenting with a presumed first-ever unprovoked seizure (2000) (38)
EEG and Topographic Frequency Analysis in Common and Classic Migraine (1991) (38)
Thrombin receptor PAR-1 on myelin at the node of Ranvier: a new anatomy and physiology of conduction block. (2008) (38)
Dementia in the COVID-19 Period (2020) (37)
Cognitive State following Stroke: The Predominant Role of Preexisting White Matter Lesions (2014) (37)
Should sleep EEG record always be performed after sleep deprivation? (1994) (37)
Effects of propranolol and pindolol on platelet aggregation and serotonin release. (1977) (37)
[Transdermal therapeutic systems]. (1983) (36)
Effects of localized pontine lesions on auditory brain-stem evoked potentials and binaural processing in humans. (1998) (36)
Magnetic resonance imaging in cerebrotendinous xanthomatosis: A prospective clinical and neuroradiological study (1994) (36)
Pathophysiology of drug-induced dyskinesias. (1972) (36)
The very high prevalence of AD in an Arab population is not explained by APOE ε4 allele frequency (2000) (35)
A pilot, randomized, open‐label trial assessing safety and pharmakokinetic parameters of co‐administration of rivastigmine with risperidone in dementia patients with behavioral disturbances (2002) (35)
The Use of Intravenous Immunoglobulin as Maintenance Therapy in Myasthenia Gravis (2001) (35)
Thalamo-striatal diffusion reductions precede disease onset in prion mutation carriers. (2009) (35)
Risk factors for dementia in Parkinson's disease. (1990) (35)
Effect of rivastigmine on tremor in patients with Parkinson's disease and dementia (2006) (34)
Handbook of autonomic nervous system dysfunction (1995) (34)
Anal sphincter EMG does not distinguish between multiple system atrophy and Parkinson's disease. (2000) (34)
Mental and Motor Switching in Parkinson's Disease (2001) (34)
Tau and 14-3-3 of genetic and sporadic Creutzfeldt–Jakob disease patients in Israel (2011) (34)
Visual evoked potentials in idiopathic intracranial hypertension (2009) (34)
Oral solution of levodopa ethylester for treatment of response fluctuations in patients with advanced Parkinson's disease (2002) (33)
Neuroprotection in vascular dementia: A future path (2012) (33)
Extrapyramidal effects of neuroleptics. (1976) (33)
[Dementia in Parkinson's disease]. (1986) (33)
Comparison of the effects of vigabatrin, lamotrigine, and topiramate on quantitative EEGs in patients with epilepsy. (1999) (33)
Stroke during Sleep: Epidemiological and Clinical Features (1999) (33)
Anal sphincter EMG does not distinguish between multiple system atrophy and Parkinson's disease (2000) (33)
Vascular dementia among elderly Arabs in Wadi Ara (2002) (33)
Antibodies To Cholinergic Cell Bodies In Alzheimer’s Disease (1986) (32)
High b-value diffusion imaging of dementia: Application to vascular dementia and alzheimer disease (2007) (32)
Multiple sclerosis and birth order (1988) (32)
Parkinsonism in adult‐onset GM2 gangliosidosis (1994) (32)
Mild adolescent/adult onset epilepsy and paroxysmal exercise‐induced dyskinesia due to GLUT1 deficiency (2010) (32)
Intranuclear inclusions in oculopharyngeal muscular dystrophy among Bukhara Jews (1996) (32)
Generalized convulsive status epilepticus in Creutzfeldt–Jakob disease (2003) (32)
TBC1D24 mutation associated with focal epilepsy, cognitive impairment and a distinctive cerebro-cerebellar malformation (2013) (32)
Rotigotine transdermal system for perioperative administration (2007) (31)
Do silent brain infarctions predict the development of dementia after first ischemic stroke? (1996) (31)
Quality of life in Parkinson's disease: A gender‐specific perspective (2019) (31)
Age and sex dependency of the Achilles tendon reflex (1979) (31)
Recruitment Rate to Drug Trials for Dementia of the Alzheimer Type (2000) (31)
Parkin mutation associated parkinsonism and cognitive decline, comparison to early onset Parkinson’s disease (2004) (31)
Epilepsy subtype-specific copy number burden observed in a genome-wide study of 17 458 subjects. (2020) (30)
A paradigm for single nucleotide polymorphism analysis: The case of the acetylcholinesterase gene (2004) (30)
Physostigmine improves ECT‐induced memory disturbances (1987) (30)
Muscarinic M1 agonists in the treatment of Alzheimer’s disease (2000) (30)
The temporal and causal relationship between inflammation and neurodegeneration in multiple sclerosis (2020) (30)
A critical review of the prion hypothesis of human synucleinopathies (2018) (30)
Changes in axonal morphology in experimental autoimmune neuritis as studied by high b‐value q‐space 1H and 2H DQF diffusion magnetic resonance spectroscopy (2002) (30)
Timing and sequencing of human arm trajectories: Normal and abnormal motor behaviour (1992) (30)
Morphine mydriasis in mice. (1979) (30)
Survival in Parkinson's disease: the effect of dementia. (1998) (30)
Homocysteine, stroke, and dementia. (2002) (29)
Progressive dystonia and paraparesis in cerebral palsy. (1986) (29)
APOE-epsilon 4 in patients with Alzheimer disease and vascular dementia. (1996) (28)
Sequential serum creatine kinase determination differentiates vaso‐vagal syncope from generalized tonic‐clonic seizures (1997) (28)
Cerebral vasomotor reactivity in Parkinson's disease, multiple system atrophy and pure autonomic failure (2006) (28)
Bell's palsy and viral infections. (1973) (28)
Biomarkers for prediction and targeted prevention of Alzheimer’s and Parkinson’s diseases: evaluation of drug clinical efficacy (2010) (28)
Motor switching abilities in Parkinson’s disease and old age: temporal aspects (1998) (27)
Peripheral neuropathy in cerebrotendinous xanthomatosis (1979) (27)
Does daily aspirin diminish severity of first-ever stroke? (1997) (27)
Risk factors for Alzheimer's disease in Russia: a case–control study (2006) (27)
Phosphatidylserine Containing Omega-3 Fatty Acids May Improve Memory Abilities in Nondemented Elderly Individuals with Memory Complaints: Results from an Open-Label Extension Study (2014) (27)
Vascular and Neurodegenerative Markers for the Prediction of Post-Stroke Cognitive Impairment: Results from the TABASCO Study. (2019) (27)
Demented patients' participation in a clinical trial: factors affecting the caregivers' decision (2000) (26)
Lateralization and binaural discrimination of patients with pontine lesions. (1998) (26)
Epidemiology of dementia in Ashkelon (2003) (26)
Diaphragmatic involvement in hemiplegia and hemiparesis. (1969) (26)
Parkinson's and Alzheimer's diseases: epidemiological comparison. 2. Persons at risk. (1993) (26)
CSF tau correlates with CJD disease severity and cognitive decline (2016) (26)
R‐R interval variation in Parkinson's disease and multiple system atrophy (2004) (26)
Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies (2021) (26)
Computerized methods in the assessment and prediction of dementia. (2007) (26)
Computerized diagnosis of mild cognitive impairment (2007) (26)
Genetic and environmental epidemiology of Alzheimer’s disease in arabs residing in Israel (2007) (26)
Safety profile of copolymer 1: Analysis of cumulative experience in the United States and Israel (1996) (26)
Apolipoprotein epsilon4 advances appearance of psychosis in patients with Parkinson's disease. (2006) (25)
EEG as predictor of dementia following first ischemic stroke (1994) (25)
A novel mutation of presenilin 1 in familial Alzheimer’s disease in Israel detected by denaturing gradient gel electrophoresis (1996) (25)
Quantitative measurements of mouse brain thrombin-like and thrombin inhibition activities (2001) (25)
Denbufylline in Dementia: A Double-Blind Controlled Study (1999) (25)
Familial Alzheimer's disease associated with S182 codon 286 mutation (1995) (25)
High hair cortisol concentrations predict worse cognitive outcome after stroke: Results from the TABASCO prospective cohort study (2017) (25)
Pruritus in familial Creutzfeldt–Jakob disease: a common symptom associated with central nervous system pathology (2010) (24)
Occurrence of fatigue over 20 years after recovery from Guillain–Barré syndrome (2012) (24)
Gait Measures as Predictors of Poststroke Cognitive Function: Evidence From the TABASCO Study (2015) (24)
Dyskinesias in patients with Parkinson's disease: effect of the leucine-rich repeat kinase 2 (LRRK2) G2019S mutation. (2012) (24)
Hexosaminidase A deficiency is an uncommon cause of a syndrome mimicking amyotrophic lateral sclerosis (2003) (24)
Autonomic impairment in a transgenic mouse model of amyotrophic lateral sclerosis (2011) (24)
Risk of Dementia after a First-Ever Ischemic Stroke: A 3-Year Longitudinal Study (1997) (24)
Cognitive Assessment in Proximity to Acute Ischemic Stroke/Transient Ischemic Attack: Comparison of the Montreal Cognitive Assessment Test and MindStreams Computerized Cognitive Assessment Battery (2013) (24)
Human-computer interaction in the administration and analysis of neuropsychological tests (2004) (24)
Dihydroergotamine Nasal Spray in the Treatment of Acute Migraine (1998) (24)
Patterns of daytime sleepiness in narcoleptics and normals: a pupillometric study. (1984) (24)
Involvement of the diaphragm in hemiplegia (1969) (23)
The lupus anticoagulant and dementia in non-SLE patients (1992) (23)
The pupillary effects of retrobulbar injection of botulinum toxin A (oculinum) in albino rats. (1991) (23)
Familial levodopa‐responsive parkinsonian‐pyramidal syndrome (1994) (23)
Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals. (2021) (23)
Cerebral White Matter Disruption in Creutzfeldt-Jakob Disease (2012) (23)
Inhibition of Ras attenuates the course of experimental autoimmune neuritis (2005) (23)
Management of sleep problems in Parkinson's disease (2006) (23)
Persistent hemiballism in Parkinson's disease. (1994) (22)
A Mutation in the Prion Protein Gene in Creutzfeldt‐Jakob Disease in Jewish Patients of Libyan, Greek, and Tunisian Origin (1991) (22)
Phenotypic analysis of 303 multiplex families with common epilepsies (2017) (21)
Biomarkers for evaluation of clinical efficacy of multipotential neuroprotective drugs for Alzheimer’s and Parkinson’s diseases (2011) (21)
Computed tomographic findings of brain and skull in myotonic dystrophy. (1987) (21)
Cerebral vasomotor reactivity of patients with acute ischemic stroke: Cortical versus subcortical infarcts: An Israeli–Turkish collaborative study (2007) (21)
Sodium channel localization in rat sciatic nerve following lead-induced demyelination (1985) (21)
Apolipoprotein E and Parkinson's disease (1998) (21)
Cold pressor test in tetraplegia and paraplegia suggests an independent role of the thoracic spinal cord in the hemodynamic responses to cold (2008) (21)
Preliminary observations on APOE epsilon4 allele and progression of disability in multiple sclerosis. (1999) (21)
Beneficial effect of cabergoline, new long-lasting D2 agonist in the treatment of Parkinson's disease. (1994) (21)
Antiphospholipid syndrome induction exacerbates a transgenic Alzheimer disease model on a female background (2011) (21)
Multiplex families with epilepsy (2016) (20)
Convulsive Fits in Thyrotoxicosis (1976) (20)
APOE in non-Alzheimer amyloidoses (1998) (20)
Modified Cold Pressor Test by Cold Application to the Foot After Spinal Cord Injury: Suggestion of Hemodynamic Control by the Spinal Cord (2007) (20)
Prevalence of myotonic dystrophy in Israeli Jewish communities: Inter‐community variation and founder premutations (2003) (20)
Transmission of spongiform encephalopathy from a familial Creutzfeldt‐Jakob disease patient of Jewish Libyan origin carrying the PRNP codon 200 mutation (1992) (19)
The stomatognathic system in myotonic dystrophy. (1987) (19)
Dosing with ropinirole in a clinical setting (2002) (19)
Muscarinic acetylcholine receptors in albino rabbit iris-ciliary body. (1979) (19)
Progressive myoclonus epilepsies-Residual unsolved cases have marked genetic heterogeneity including dolichol-dependent protein glycosylation pathway genes. (2021) (19)
The pupil in familial dysautonomia (1981) (19)
Hypertriglyceridemia may cause a subclinical peripheral neuropathy. (1999) (19)
Autonomic nervous system screening in patients with early Parkinson’s disease (1989) (19)
Willingness to Use Computerized Systems for the Diagnosis of Dementia: Testing a Theoretical Model in an Israeli Sample (2012) (18)
Intravenous Diazepam in Drug-Induced Dystonic Reactions (1972) (18)
Seizures as presenting and prominent symptom in chorea‐acanthocytosis with c.2343del VPS13A gene mutation (2016) (18)
Epidemiology of dementia in Ashkelon: the influence of education. (2003) (18)
The assessment of radiating low back pain by thermal sensory testing (2001) (18)
Analysis of genetic polymorphisms in acetylcholinesterase as reflected in different populations. (2005) (18)
Evaluation of a Short Mental Test for the Diagnosis of Dementia (1990) (18)
Transient musical hallucinosis. (1993) (17)
Dementia in Parkinson's disease (2001) (17)
Epilepsy, behavior, and art (Epilepsy, Brain, and Mind, part 1) (2013) (17)
Quality‐of‐life perception by Parkinson's disease patients and caregivers (2017) (17)
Depressive symptoms following stroke and transient ischemic attack: is it time for a more intensive treatment approach? results from the TABASCO cohort study. (2016) (17)
The role of apolipoprotein E polymorphisms in levodopa‐induced dyskinesia (2011) (17)
The sympathetic skin response in reflex sympathetic dystrophy (1995) (17)
Intermittent rhythmic delta activity (IRDA) morphology cannot distinguish between focal and diffuse brain disturbances (1999) (17)
Transient bilateral diaphragmatic paralysis. (1973) (17)
Genetic and environmental factors determining the development of Creutzfeldt-Jakob disease in Libyan Jews. (1991) (17)
An open trial of amantadine and buspirone for cerebellar ataxia: a disappointment (2000) (17)
Cognitive state following mild stroke: A matter of hippocampal mean diffusivity (2016) (17)
The Role of Sex Therapy in the Management of Patients with Parkinson's Disease (2018) (17)
Routine and quantitative EEG analysis in Gilles de la Tourette's syndrome (1990) (17)
The electroencephalogram in acetazolamide‐responsive periodic ataxia (1996) (17)
Creutzfeldt-Jakob disease among libyan jews (1991) (17)
Founder Effect with Variable Age at Onset in Arab Families with Lafora Disease and EPM2A Mutation (2007) (17)
Assessment of experimental autoimmune neuritis in the rat by electrophysiology of the tail nerve (2002) (16)
Abolition of oxotremorine effects by l-DOPA pretreatment (1979) (16)
The very high prevalence of AD in an Arab population is not explained by APOE epsilon4 allele frequency. (2000) (16)
Antiphospholipid Antibodies Bind ATP: A putative Mechanism for the Pathogenesis of Neuronal Dysfunction (2005) (16)
A Randomised, Double-Blind, Placebo-Controlled Trial of Actovegin in Patients with Post-Stroke Cognitive Impairment: ARTEMIDA Study Design (2013) (16)
The clinical differential diagnosis of dementia: concept and methodology. (1991) (15)
Interrater Agreement in Evaluation of Stroke Patients With the Unified Neurological Stroke Scale (1994) (15)
Electroencephalographic findings with low-dose clozapine treatment in psychotic Parkinsonian patients. (1996) (15)
VISUAL CONTROL OF ARM MOVEMENT IN PARKINSON'S DISEASE (1996) (15)
Copolymer 1 (Glatiramer Acetate) in Relapsing Forms of Multiple Sclerosis: Open Multicenter Study of Alternate-Day Administration (2002) (15)
Neuroprotection in ischemic stroke: what does the future hold? (2015) (15)
Magnetic resonance imaging (MRI) in patients with complex partial seizures and normal computerized tomography (CT) scan (1987) (14)
The Price of Stress: High Bedtime Salivary Cortisol Levels Are Associated with Brain Atrophy and Cognitive Decline in Stroke Survivors. Results from the TABASCO Prospective Cohort Study. (2018) (14)
Can the disease course in Parkinson’s disease be slowed? (2015) (14)
Muscarinic acetylcholine receptors in cat iris. (1979) (14)
Spongiform encephalopathy in an Israeli born to immigrants from Libya (1990) (14)
Parkinson's disease: one disease entity or many? (1999) (14)
Seizures of unknown origin after the age of 50: vascular risk factors (1990) (14)
N30 somatosensory evoked potentials in patients with unilateral Parkinson's disease (1998) (14)
EEG in Cerebrotendinous Xanthomatosis (CTX) (1982) (14)
Waardenburg syndrome with a fixed dilated pupil. (1978) (14)
Effects of atropine on learning and memory functions in dementia. (1990) (14)
Tolerance to the analgesic effect of buprenorphine, butorphanol, nalbuphine, and cyclorphan, and cross-tolerance to morphine (2001) (14)
Carbamazepine induced systemic lupus erythematosus. (1989) (13)
Physically traumatic events in patients with epilepsy compared with non-epileptic subjects (2000) (13)
Familial Creutzfeldt–Jakob disease with the E200K mutation: longitudinal neuroimaging from asymptomatic to symptomatic CJD (2015) (13)
Evoked potential studies in the antiphospholipid syndrome: differential diagnosis from multiple sclerosis (2005) (13)
SERUM ANTIBODIES TO CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE (1989) (13)
Central and peripheral components of morphine mydriasis in mice (1982) (13)
Is dementia preventable? (2009) (13)
Identification of Histidine‐Rich Glycoprotein, a Potential Autoantigen, in Human and Rat Brain Preparations (2007) (13)
Lack of limb motor asymmetry in the neonate. (1978) (13)
The pupil cycle time in Horner's syndrome. (1986) (13)
Switching abilities in Parkinson's disease. (1996) (13)
Decreased (3H) quinuclidinyl benzilate binding to lymphocytes in Gilles de la Tourette syndrome (1992) (13)
Germline mutational analysis of presenilin 1 and APP genes in Jewish-Israeli individuals with familial or early-onset Alzheimer disease using denaturing gradient gel electrophoresis (DGGE) (1998) (13)
Dissociated sensory loss and visual evoked potentials in a patient with pernicious anemia. (1980) (13)
Unusual presentations in patients with E200K familial Creutzfeldt−Jakob disease (2016) (13)
Infections as triggering factors for ischemic stroke (1997) (13)
O1-03-02 Computer based cognitive training with mindfit® improved cognitive performances above the effect of classic computer games: Prospective, randomized, double-blind intervention study in the elderly (2007) (13)
Changes in expression of lymphocyte amyloid precursor protein mRNA isoforms in normal aging and Alzheimer's disease. (1996) (12)
Retinal red-free light photographs in two congenital conditions: a case of optic hypoplasia and a case of congenital hemianopia. (1976) (12)
Correlation of Headache Complaints With Some Physiological Parameters in a Healthy Population (1980) (12)
Hamilton Depression Scale in dementia (2002) (12)
DSM‐III Criteria for Primary Degenerative Dementia and Multi‐Infarct Dementia (1992) (12)
Safety of phosphatidylserine containing omega-3 fatty acids in non-demented elderly: a double-blind placebo-controlled trial followed by an open-label extension (2011) (12)
Dopaminergic drugs in development for Parkinson's disease. (2003) (12)
Parkinson's and Alzheimer's diseases: epidemiological comparison. 1. Descriptive aspects. (1993) (12)
Long‐term tolerability and efficacy of cabergoline, a new long‐acting dopamine agonist, in Parkinson's disease (1995) (12)
Instrumental Methods and Scoring in Extrapyramidal Disorders (1995) (12)
Modeling the Dementia Epidemic (2012) (12)
Enkephalin mydriasis in mice. (1980) (12)
Sympathetic pupillary activity in infants. (1977) (12)
Hemodynamic responses to head-up tilt after spinal cord injury support a role for the mid-thoracic spinal cord in cardiovascular regulation (2011) (12)
Is amnestic mild cognitive impairment a useful concept (2011) (12)
The Creutzfeldt–Jakob disease (CJD) neurological status scale: a new tool for evaluation of disease severity and progression (2011) (12)
Immunohistochemical analysis of sympathetic involvement in the SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis (2013) (12)
Is vascular cognitive impairment a useful concept? (2010) (11)
Nicotinic acetylcholine receptor α5 subunits modulate oxotremorine-induced salivation and tremor (2004) (11)
Dopaminergic and non-dopaminergic circling activity of mice (1979) (11)
Third International Congress on Epilepsy, Brain and Mind: Part 1 (2015) (11)
Visual disturbances in Parkinson’s disease (2006) (11)
21 – Development of Manual Laterality and Language Function (1983) (11)
Postmeningitis Headache (1999) (11)
Encephalopathy Associated with Sulindac (1986) (11)
EFFECT OF BRAIN STEM TRANSECTIONS ON VASOMOTOR RESPONSES TO NERVE STIMULATION. (1963) (11)
Esophageal smooth muscle dysfunction in oculopharyngeal muscular dystrophy (1996) (11)
Dementia in Parkinson's disease (1986) (11)
Characterization of sleep disorders in patients with E200K familial Creutzfeldt–Jakob disease (2015) (11)
Cardiovascular effects of lobeline. (1969) (11)
Topographic distribution of the periodic discharges in Creutzfeldt-Jakob disease (CJD) (2005) (11)
Vascular Contribution to Dementia in Parkinson’s Disease (2010) (10)
Laterality of onset in idiopathic torsion dystonia (1993) (10)
Increased KPI containing amyloid precursor protein in experimental autoimmune encephalomyelitis brains (2007) (10)
The effect of dopamine on the pupillary diameter in mice. (1980) (10)
Inhibition of ras by farnesylthiosalicylate significantly reduces the levels of autoantibodies in two animal models of the antiphospholipid syndrome. (2003) (10)
Neurologic genetic diseases of Jewish people. (1994) (10)
Lay persons' beliefs and knowledge about Parkinson's disease: prevalence and socio-demographic correlates. (2010) (10)
Blood pressure measurements in a transgenic SOD1-G93A mouse model of amyotrophic lateral sclerosis (2012) (10)
Amethocaine and Intraocular Pressure (1979) (10)
[Creutzfeld-Jakob disease and its relation to pre-senile dementia]. (1969) (9)
Can treatment with nonsteroidal anti-inflammatory drugs protect from dementia? (2009) (9)
Original contributions White matter changes in multiple sclerosis: correlation of q-space diffusion MRI and 1 H MRS (2005) (9)
Insulin resistance in tetraplegia but not in mid-thoracic paraplegia: is the mid-thoracic spinal cord involved in glucose regulation? (2011) (9)
Subdivision of essential tremor patients according to physiologic characteristics (2004) (9)
Phenotypic heterogeneity in familial inclusion body myopathy (1995) (9)
Parkinson's and Alzheimer's diseases: Focus on mild cognitive impairment. (2016) (9)
Acquired Oculomotor Nerve Paresis with Cyclic Spasms in a Young Woman, a Rare Subtype of Neuromyotonia (2013) (9)
Mild cognitive impairment in Parkinson’s disease (2013) (9)
ANTAGONISM OF OPIATE MYDRIASIS IN MICE (1981) (9)
Hidden function of neuronal nicotinic acetylcholine receptor β2 subunits in ganglionic transmission: comparison to α5 and β4 subunits (2005) (9)
Characterization of movement disorders in patients with familial Creutzfeldt-Jakob disease carrying the E200K mutation. (2012) (9)
[Enkephalins and endorphins]. (1979) (9)
A Practical Measurement of Parkinson's Patients Gait Using Simple Walker-Based Motion Sensing and Data Analysis (2018) (9)
Drugs for vascular dementia (2007) (8)
Effect of pilocarpine on intraocular pressure in ocular hypertensive subjects. (1986) (8)
The chick as a model for malignant hyperpyrexia. (1980) (8)
The vestibulo-ocular reflex and dysequilibrium after hemispheric stroke. (1994) (8)
Cognitive effects of scopolamine in dementia (2005) (8)
Sympathomimetic amines and cardiac arrhythmias. (1990) (8)
Cardiac manifestations of myotonic dystrophy. (1989) (8)
Penetrance and Phenotypic Expression of a Mutation Linked to Creutzfeldt-Jakob Disease in the Elderly (1998) (8)
Computed tomography brain changes in Parkinsonian dementia (2004) (8)
Vasomotor reactivity as a predictor for syncope in patients with orthostatism (2012) (8)
Late-life depression as a risk factor for dementia (2007) (8)
Clinical course of idiopathic torsion dystonia among Jews in Israel. (1988) (8)
Headache in Patients with Hypertension (1978) (8)
Disease duration in E200K familial Creutzfeldt–Jakob disease is correlated with clinical, radiological, and laboratory variables (2018) (8)
Central actions of regitine (phentolamine) on blood pressure. (1967) (7)
The Hoehn and Yahr Rating Scale for Parkinson’s Disease (1995) (7)
Cerebral atherosclerosis in Parkinsonian patients. (1998) (7)
Neuroanatomical aspects of mydriatic action of morphine in rats. (1997) (7)
Respiratory and cardiac abnormalities in brain-stem ischaemia. (1975) (7)
The Lived Experience of Parkinson's Disease: A Content Analysis of Parkinson's Patients' Blogs. (2017) (7)
Comment: should we diagnose MCI in Parkinson disease? (2011) (7)
The stability of dopamine-β-hydroxylase activity in blood samples (1978) (7)
Mydriasis induced by tetrahydrocannabinol (THC) in rats. (1982) (7)
Inhibition of hypertensive reflexes by propranolol. (1974) (7)
Quality of life in Alzheimer's disease (1999) (7)
Natural course of idiopathic torsion dystonia among Jews. (1994) (7)
Rats immunized with cholinergic synaptosomes: A model for Lambert‐Eaton syndrome (1990) (7)
Is Alzheimer’s disease a homogeneous disease entity? (2013) (7)
Cerebrovascular symptoms in thromboangiitis obliterans (1989) (7)
Selective Signaling Via Novel Muscarinic Agonists: Implications for Alzheimer’s Disease Treatments and Clinical Update (1994) (7)
Decreased dopamine uptake into platelet storage granules in Gilles de la Tourette disease (1995) (6)
Pure congenital Foix‐Chavany‐Marie syndrome (1997) (6)
Lack of association between angiotensin-converting enzyme and dementia of the Alzheimer’s type in an elderly Arab population in Wadi Ara, Israel (2005) (6)
Antibodies to muscarinic acetylcholine receptors in myasthenia gravis. (1982) (6)
Benign Neonatal Sleep Myoclonus (2012) (6)
Third International Congress on Epilepsy, Brain, and Mind: Part 2 (2015) (6)
Alzheimer's disease and vascular brain lesions (2005) (6)
The pathophysiology of dystonia (2005) (6)
Familial Creutzfeldt–Jakob disease homozygous to the E200K mutation: clinical characteristics and disease course (2020) (6)
Somatostatin mydriasis in mice. (1983) (6)
Hidden function of neuronal nicotinic acetylcholine receptor beta2 subunits in ganglionic transmission: comparison to alpha5 and beta4 subunits. (2005) (6)
Understanding changes in cholinergic function: implications for treating dementia. (2002) (6)
Dementia with Lewy bodies (2006) (6)
Is there a need to redefine Parkinson's disease? (2011) (6)
Denervation supersensitivity in the canine heart: catecholamine-enhanced positive chronotropy without altered arrhythmogenicity. (1982) (6)
Ocular tension: comparison between the two eyes. (1985) (6)
Emerging Therapies in the Pharmacological Treatment of Parkinson’s Disease (2012) (6)
Heparin in the treatment of acute stroke. (1992) (6)
Clinical and radiological determinants of transient symptoms associated with infarction (TSI) (2018) (6)
Painful calf, moving foot (1996) (6)
Increased platelet aggregation and release reaction in myotonic dystrophy (1988) (5)
Amantadine antagonism of oxotremorine effects (2005) (5)
Naloxone fails to improve memory and cognitive disturbances after electroconvulsive treatment (1990) (5)
[Prevalence of APO e4 allele in Israeli ethnic groups]. (1999) (5)
Circadian rhythm of the pupillary response to morphine and to naloxone. (1985) (5)
Evaluation of the Hachinski Ischemic Scale in a Prospective Study (1992) (5)
Lack of effect of cannabinoids on carbonic anhydrase (2005) (5)
TRANSCRANIAL MAGNETIC STIMULATION OF DEEP BRAIN REGIONS IN ALZHEIMER'S DISEASE (2014) (5)
Dopaminergic drugs influence the intensity of catalepsy induced by microinjections of carbachol into the reticular formation (1990) (5)
Denervation supersensitivity in Horner's Syndrome. (1975) (5)
Carpal tunnel syndrome: A complication of idiopathic torsion dystonia (1991) (5)
Adrenergic denervation supersensitivity. (1975) (5)
Asymmetry of turning behaviour of rats induced by amphetamine and apomorphine (1978) (5)
Clinical diagnosis of Alzheimer's disease (AD) (1994) (5)
5‐hydroxytryptamine in platelets of torsion dystonia patients (1985) (5)
[Hyperbaric oxygen treatment of multiple sclerosis]. (1986) (5)
P2-406: Improving cognitive performance in elderly subjects using computerized cognitive training (2008) (5)
Treating tardive dyskinesia with ondansetron. (2001) (5)
Targeted resequencing in epileptic encephalopathies reveals marked genetic heterogeneity and novel genes (2013) (5)
Aetiology of Bell's palsy. (1971) (5)
Cerebral vasomotor reactivity and dementia after ischemic stroke (2010) (5)
What is new in vascular dementia? (2016) (5)
Central connections of the salivation reflex in man (1978) (4)
CLONIDINE FOR OPIATE WITHDRAWAL (1980) (4)
Costs of illness and care in Parkinson's disease (2011) (4)
Scanning electron microscope study of erythrocytes from patients with myopathy. (1977) (4)
Antineurofilament antibodies in postpolio syndrome (1998) (4)
Smoking and Drug-induced Parkinsonism (1987) (4)
Electroretinographic responses in Lafora disease. (1978) (4)
Depression Inventories in Parkinson’s Disease (1995) (4)
Subject Index Vol. 12, 1993 (1993) (4)
Does pupillary sparing oculomotor nerve palsy really spare the pupil? (1991) (4)
Vestibulo-ocular reflex suppression following hemispheric stroke. (1993) (4)
Feasibility of an instrumented walker to quantify treatment effects on Parkinson's patient gait (2018) (4)
Electrocardiographic abnormalities in patients with brain-stem tumors. (1971) (4)
Apolipoprotein E4 in Parkinson's disease (1995) (4)
Genomic imprinting and anticipation in idiopathic torsion dystonia (1993) (4)
Non‐Migrainous Headache and Transient Neurological Deficits (1985) (4)
Effect of brain stem transections on blood pressure responses, evoked by afferent nerve stimulation in the cat. (1965) (4)
Action of opioid agonist-antagonist drugs on the pupil and nociceptive responses in mice (1992) (4)
Effect of Pentobarbitone on Respiratory Responses to Nerve Stimulation (1965) (4)
Vascular parkinsonism. (2007) (4)
Meningococcal disease with cardiac death. A case report. (1971) (4)
DOPAMINE-BETA-HYDROXYLASE (DBH) AND PUPILLARY SYMPATHETIC ACTIVITY IN IDIOPATHIC TORSION DYSTONIA (ITD) (1979) (4)
Respiratory responses to brain stem stimulation. (1966) (4)
Long-term tetrahydroaminoacridine treatment and quantitative EEG in Alzheimer's disease. (2007) (4)
CSF tau correlates with the degree of cortical involvement in E200K familial Creutzfeldt-Jakob disease (2016) (4)
Drug trials in dementia: challenging ethical dilemmas. (2007) (4)
Neuropsychiatric manifestations in Parkinson's disease. (2001) (4)
Cardiac denervation supersensitivity produced in guinea pigs by 6-hydroxy-dopamine. (1984) (4)
Comparison of efficacy of lisuride hydrogen maleate with increased doses of levodopa in parkinsonian patients. (1987) (4)
Bacillus epilepticus (1994) (4)
Gilles de la Tourette syndrome: EEG and mapping (1989) (3)
REY AUDITORY VERBAL LEARNING TEST AS A TOOL FOR DIAGNOSIS OF MILD COGNITIVE IMPAIRMENT (2010) (3)
The yield of repeated awake EEG's in the confirmation of epilepsy (1991) (3)
Lingual Seizures1 (1988) (3)
Saccade Characteristics in Patients with Hemispheric Stroke (1997) (3)
Computerized Methods for Cognitive Testing (2008) (3)
Pharmacological responses of pupillary smooth muscle in myopathies. (1977) (3)
Mental Dysfunction in Parkinson's Disease (2014) (3)
Asymptomatic carotid artery stenosis (ACAS) (2011) (3)
Possible remote functional reorganization in left temporal lobe epilepsy (2008) (3)
Apolipoprotein E ε4 Allele Does Not Influence the Development of Dementia in Parkinsonian Patients (1998) (3)
Precipitation of Hereditary Motor–Sensory Neuropathy Following Hepatitis B Vaccination (2001) (3)
[Familial Behcet disease]. (1973) (3)
The specificity of the pupillary actions of morphine and naloxone. (1987) (3)
Juvenile segmental muscular atrophy. (1991) (3)
Israeli society for EEG and clinical neurophysiology (1985) (3)
Ischaemic cranial neuropathies. (1971) (3)
Gastric Dysfunction in Parkinson’s Disease (2013) (3)
The gut in PD (1993) (3)
Nonarteritic Ischemic Optic Neuropathy and Other Vascular Diseases (2013) (3)
Effect of pilocarpine on intraocular pressure in normal humans. (1982) (3)
The effect of L-dopa on pupillary diameter in mice (1982) (3)
Effect of brain stem transections on respiratory responses to electrical stimulation of the medulla oblongata. (1967) (3)
Sexual function in multiple sclerosis (2011) (3)
Clinical radiological correlation in E200K familial Creutzfeldt–Jakob disease (2016) (3)
HIGH BLOOD PRESSURE AND DEMENTIA. AUTHORS' REPLY (1996) (3)
The pupil and vigilance. (1987) (3)
Newer therapies for Parkinson's disease. (1996) (3)
Posttraumatic Stress Symptoms After Stroke: The Effects of Anatomy and Coping Style (2022) (3)
The effect of schooling on reported age of onset of cognitive decline: A collaborative study (2016) (3)
Recruitment for drug studies in dementia. (2002) (3)
APOE‐ε4 in age‐related memory complaints and Alzheimer's disease (1996) (3)
Binaural Click Lateralization: Evidence from Psychophysics and Brainstem Evoked Potentials in Normal Subjects and Multiple Sclerosis Patients (1992) (3)
Serum dopamine beta-hydroxylase activity in acute cardiac disease. (1978) (3)
[Cerebrotendinous xanthomatosis (author's transl)]. (1977) (3)
IRS 2 Insulin receptor substrate-2 (2017) (3)
Interactions between chlorpromazine and some of its metabolites. (1980) (3)
EEG recordings following intrathecal iohexol administration. (1990) (3)
[Depression precedes development of dementia]. (2008) (3)
Gait instability in valproate‐treated patients: Call to measure ammonia levels (2017) (3)
Effect of brain transections on the respiratory response to nerve stimulation. (1965) (3)
Comments on the article by Mazza et al. concerning Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo‐controlled double‐blind study (2007) (2)
Atypical duration of epileptic and psychogenic nonepileptic events (2020) (2)
The beneficial effect of chronic lisuride administration compared with levodopa in Parkinson's disease. (1990) (2)
DSM-III-R criteria for primary degenerative dementia and multi-infarct dementia [corrected]. (1992) (2)
The Use of Biomarkers for Prediction and Prevention of Alzheimer’s and Parkinson’s Diseases (2013) (2)
Life Style and the Prevention of Dementia (2015) (2)
Prevalence of diabetes mellitus in Bell's palsy. (1971) (2)
Selective lesion of neurons in primary cell cultures by MPTP and ethylcholine aziridinium ion (AF64A). (1987) (2)
Creutzfeldt-Jakob and Vascular Brain Diseases: Their Overlap and Relationships (2021) (2)
Prolongation of responses in decentralization supersensitivity. (1976) (2)
Sexuality and Parkinson’s Disease (2003) (2)
Prevention of Recurrent Stroke (1991) (2)
Dopamine uptake by platelet storage granules in first-degree relatives of Tourette’s syndrome patients (1998) (2)
Pilocarpine mydriasis in mice. (1985) (2)
Standardized quantitative measurements in Parkinson's disease. (1999) (2)
High blood pressure and dementia (1996) (2)
MATTERS ARISING (1995) (2)
43 Why have we failed to cure Alzheimer's disease? (2012) (2)
A statistical method for quantitative evaluation of the progression of chronic diseases: the mean score graph (MSG). (1998) (2)
Dr. Sirota and Colleagues Reply (2001) (2)
Saccadic responses in patients with hemispheric stroke (2005) (2)
Concerning "visual control of arm movement in Parkinson's disease". (1996) (2)
Dopamine-β-hydroxylase (DBH) in idiopathic torsion dystonia (ITD) (1982) (2)
Extending our Understanding of the Dopaminergic Basis of Non-motor Symptoms in Parkinson's Disease Highlights of a Britannia symposium held at the 10th International Congress on Non-Motor Dysfunctions in Parkinson's Disease and Related Disorders, 5th December 2014, Nice, France (2015) (2)
Effect of beta-blockers on sodium and potassium content of human erythrocytes. (1979) (2)
Effect of amantadine on pupillary diameter in mice. (1982) (2)
[Mild cognitive impairment (MCI): characteristics, risk factors and prevention]. (2006) (2)
Prion diseases (1997) (2)
On the origin of the Hering-Traube waves (HTW). (1967) (2)
Serial EEG Recordings following Intrathecal Metrizamide Administration (1989) (2)
Vascular dementia 2003 (2005) (2)
Dopamine-beta-hydroxylase (DBH) in idiopathic torsion dystonia (ITD). (1982) (2)
The probenecid test. (1983) (1)
Surveying Global Availability of Parkinson's Disease Treatment. (2022) (1)
Carbamazepine-induced systemic lupus erythematosus. (1989) (1)
New drugs and vagal stimulation for treatment of epilepsy--the Israeli experience. (1996) (1)
Smoking and amyotrophic lateral sclerosis (2009) (1)
Prostaglandins do not affect ion concentrations in human erythrocytes. (1979) (1)
Torsion dystonia in jews and non‐jews (1991) (1)
The assessment of cognitive and behavioural disturbances in vascular cognitive impairment (VCI) - recommendations of an expert working group. (2021) (1)
Presenile dementia in Israel (1987) (1)
Effect of electroconvulsive treatment on serum dopamine-beta-hydroxylase activity in man (1978) (1)
[The use of alternative medicine by multiple sclerosis patients]. (2002) (1)
Vascular dementia 2007 (2009) (1)
Preface (2011) (1)
[Superficial sensation, deep sensation]. (1982) (1)
The stability of dopamine-beta-hydroxylase activity in blood samples. (1978) (1)
The Epidemiology of Alzheimer’s Type Presenile Dementia in Israel (1986) (1)
Autonomic dysfunction in experimental autoimmune neuritis: Heart rate (2001) (1)
[Dantrolene in the treatment of spasticity]. (1978) (1)
Alzheimer's disease research progress in the Mediterranean region: The Alzheimer's Association International Conference Satellite Symposium (2022) (1)
Arrhythmogenic effect of epinephrine. (1984) (1)
AD: Are we intervening too late? (2011) (1)
Dopamine-beta-hydroxylase activity in serum of patients with hepatic damage. (1979) (1)
Acetylcholinesterase Inhibitors in the Treatment of Dementia in Parkinson’s Disease (2003) (1)
Vascular dementia 2009 (2010) (1)
PO18-WE-04 Neuroepidemiology and genetics of epilepsy among Jews and Arabs in Israel (2009) (1)
Retraction: Familial Alzheimer's disease associated with S182 codon 286 mutation (1996) (1)
Quantitative EEG in Alzheimer's patients and age-matched controls following a single acute intravenous dose of scopolamine (1993) (1)
Absence of prion protein mutation in bipolar manic–depressive patients (1992) (1)
Vascular Dementia (2002) (1)
[The physiological action of serotonin in the brain]. (1976) (1)
PS-63-1 Tests of autonomic dysfunction in patients with multiple sclerosis (1995) (1)
Pupillary responses and blink reflex in myotonic dystrophy (1992) (1)
Commentary on “A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.” Comments from abroad (2009) (1)
[The mechanism of synaptic inhibition]. (1971) (1)
Idiopathic Parkinson's syndrome. Preface. (2011) (1)
Nociceptive circling and naloxone. (1983) (1)
Preface to special issue on Mental Dysfunction in Parkinson's Disease (2010) (1)
Lack of association between angiotensin- converting enzyme and dementia of the Alzheimer's type in an elderly Arab population (2005) (1)
Delayed Start, Rapid Solution? (2010) (1)
MRI parameters of Alzheimer’s disease in an Arab population of Wadi Ara, Israel (2005) (1)
Editorial Comments: Is multiple sclerosis a neurodegenerative or inflammatory disease? (2013) (1)
The function of presynaptic dopamine receptors on noradrenergic nerve terminals. (1979) (1)
Kinematic Analysis of Complex Movements in Parkinson’s Disease (1995) (1)
Can the RAVLT predict deterioration from MCI to dementia? Data from long term follow up (2021) (1)
Hereditary juvenile-onset craniocervical predominant generalized dystonia with parkinsonism. (2000) (1)
Education and Dementia (1998) (1)
Monitoring of Parkinson’s Patients Gait Using Simple Walker Based Motion Sensing and Data Analysis (2017) (1)
Pain and hyperpathia in pontine haemorrhage (2004) (1)
Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals. (2021) (1)
A second conponent of atropine mydriasis. (1977) (1)
Tolerance to the mydriatic effects of morphine in mice (1980) (1)
Abstract TMP92: Keep On Working. Occupational Status Before and After Stroke Protects the Brain, General Health and Cognitive Status (2018) (1)
Myoclonic-astatic epilepsy: Consanguineous families suggest autosomal recessive inheritance (2007) (1)
Opioid mydriasis: cross-tolerance between morphine and enkephalins. (1986) (1)
Lack of Association between Angiotensin-Converting Enzyme and Dementia of the Alzheimer ' s Type in an Elderly Arab Population in Wadi Ara , (2005) (1)
Plasmapheresis in Guillain‐Barré syndrome (1996) (1)
Apneustic respiration after unilateral brain stem lesions. (1971) (1)
Sensory deficit in Bell's palsy. (1970) (1)
On the usability of computerized cognitive tests for dementia screening (2005) (1)
Transdermal physostigmine-absence of effect on topographic brain mapping. (1993) (1)
Possible duplicate publication. Authors' reply (2002) (0)
Lymphocyte Amyloid Precursor Protein mRNA Isoforms in Normal Aging and Alzheimer’s Disease (1996) (0)
[Post-traumatic epilepsy]. (1986) (0)
PS-7-7 Effect of body cooling in patients with multiple sclerosis. A clinical and electrophysiological study (1995) (0)
ENHANCED PLATELT RELEASE REACTION, INCREASED PLATELET AGGREGATION (PA) AND PLATELET THROMBOXANE B2 (TXB2) GENERATION IN MYOTONIC DYSTROPHY (1987) (0)
Epilepsy and driving (1988) (0)
WS-26-2 Brain stem reflexes (1995) (0)
Sex-ratio in chorea associated with systemic lupus erythematosus and hypoparathyroidism. Role of sex hormones (1978) (0)
Disease course modification in Parkinson’s disease (2015) (0)
COVID-19 and the World Congress on Controversies in Neurology (2020) (0)
Vascular Dementia (VD) and Primary Degenerative Dementia (PDD): Criteria for Differential Diagnosis (1990) (0)
1084 – LONG-TERM PHENOTHIAZINE TREATMENT: EXTRAPYRAMIDAL EFFECTS (1977) (0)
Can neuroimaging help solve the mind–body problem? (2013) (0)
4-36-08 Epidemiology of Creutzfeld-Jakob disease (CJD) in Israel, updated (1997) (0)
[Respiratory center sensitivity in multiple sclerosis]. (1982) (0)
Towards a computerized estimation of visual complexity in images: Data to assess the association of computed visual complexity features to human responses in visual tasks (2020) (0)
[The real and ideal in the evaluation of functional competence among demented patients]. (2002) (0)
Contents Vol. 54, 2020 (2020) (0)
HLA-DRB 1 * 15 , Low Infant Sibling Exposure , and Multiple Sclerosis Gene – Environment Interaction (2010) (0)
Peripapillary retinal nerve fiber layer thickness in patients with Parkinson’s disease and multiple system atrophy (2011) (0)
[Painless sensory trigeminal neuropathy]. (1977) (0)
Subtype definition of vascular parkinsonism. (2018) (0)
PS-31-8 The sympathetic skin response: latency and amplitude asymmetry in normal subjects (1995) (0)
Editorial comments: treatment of motor fluctuations in Parkinson’s disease (2011) (0)
Mydriasis Induced by Δ1-Tetrahydrocannabinol in Rats (1983) (0)
IN44-WE-01 The role of APOE polymorphism in drug responses in alzheimer & parkinson (2009) (0)
4-30-02 Movement disorders in prion diseases (1997) (0)
The prevalence of antiphospholipid antibodies in patients with dementia (1991) (0)
Announcements February 2004 (2004) (0)
IV.13 Therapy of psychosis in Parkinson's Disease (2006) (0)
[Alzheimer's disease and amyloid protein--in (transgenic) mice and man]. (1992) (0)
[Brain concussion]. (1988) (0)
Toxic exposure and Parkinson's disease. (2006) (0)
Parkinson/Dementia complex and Lewy body dementia: perspectives and treatments (2008) (0)
IC-P2-151: The use of a virtual action planning supermarket: VAP-S for the diagnosis of mild cognitive impairment (2008) (0)
Growth Is Only Part of It (1977) (0)
THE VESTIBULO‐OCULAR REFLEX AND DYSEQUILIBRIUM AFTER HEMISPHERIC STROKE1 (1994) (0)
Subject Index Vol. 10, 1991 (1991) (0)
P-134 Screening for dementia in the elderly community (2007) (0)
Reply (1989) (0)
Effects of uncertainty on switching abilities in Parkinson's disease (PD) (1995) (0)
The sympathetic skin response: latency and amplitude asymemtry in normal subjects (1995) (0)
00 COPERTINA N1 2011 7.0:COP (2011) (0)
[Hemiparesis and convergence spasm associated with herpes zoster]. (1983) (0)
Lay persons’ beliefs and knowledge about mild cognitive impairment (2011) (0)
Oculopharyngeal Muscular Dystrophy (2003) (0)
Editorial comment: is essential tremor a neurodegenerative disease? (2012) (0)
Forthcoming Meetings (2001) (0)
Toxic exposure and Parkinson's disease. Authors' reply (2006) (0)
Action of phentolamine on respiratory reflexes in the rabbit. (1967) (0)
[Brain transplantation in Parkinson's disease]. (1991) (0)
3.051 POLYMORPHISMS IN THE SLC6A3 GENE ENCODING FOR THE DOPAMINE TRANSPORTER ARE ASSOCIATED WITH LEVODOPA-INDUCED DYSKINESIA IN PARKINSON'S DISEASE (2012) (0)
Letter to the editor (1980) (0)
Contents Vol. 53, 2019 (2019) (0)
Contents Vol. 10, 1991 (1991) (0)
Transdermal therapy in Parkinson's disease (2007) (0)
[Adrenergic receptors]. (1970) (0)
Contents Vol. 12, 1993 (2004) (0)
N30 somatosensory evoked potential in patients with unilateral Parkinson's disease (1996) (0)
Front & Back Matter (2012) (0)
A New Focus of Creutzfeldt-Jakob Disease? (2009) (0)
[The cerebral circulation]. (1977) (0)
Cortical lesions associated with transient neurological symptoms – not always a matter of cause and effect (2003) (0)
Latent Cognitive Impairment: Association with Carotid Disease (P04.227) (2013) (0)
Duration and factors affecting postictal EEG slowing following generalized tonic-clonic seizures of unknown origin (1993) (0)
Epilepsy and mental retardation limited to females (EFMR): Underrecognition of a remarkable phenotype and confirmation of linkage (2004) (0)
Autonomic function of neuronal nicotinic acetylcholine receptor subunits _5, _2 and _4: study in knockout mice (2004) (0)
CONy 2016: Controversies in Neurology were ignited in Lisbon and acknowledged in the International Journal of Clinical Neurosciences and Mental Health (2016) (0)
Intimacy, parkinson’s disease and dementia in the time of the coronavirus (2020) (0)
[New concepts on the physiology of sleep: the natural sleep]. (1970) (0)
Deprenyl in Parkinson's disease (1996) (0)
Treatment of advanced Alzheimer's disease with cholinesterase inhibitors (2008) (0)
reviews Title : Aggravated stuttering following subthalamic deep brain stimulation in (2011) (0)
Upcoming Meetings Related to Alzheimer's Disease. (2016) (0)
4-12-02 The presence of apolipoprotein E ϵ4 allele in Parkinsonian patients does not influence the development of dementia (1997) (0)
Serum dopamine beta-hydroxylase (D beta H) levels during tilting in patients with spinal cord injuries. (1980) (0)
2.115 PERIPAPILLARY RETINAL NERVE FIBER LAYER THICKNESS IN PATIENTS WITH PARKINSON'S DISEASE AND MULTIPLE SYSTEM ATROPHY (2012) (0)
Clinical Note Unilateral Thermal Anaesthesia (2002) (0)
Platelet abnormalities in myotonic dystrophy (1987) (0)
Syncope Update 1999: Syncope and Orthostatic Intolerance (1999) (0)
Mortality in Parkinson’s disease (2007) (0)
Announcements (1961) (0)
Immunohistochemical Analysis Reveals Sympathetic Column Involvement in the SOD1 (G93A) Transgenic Mouse Model of Amyotrophic Lateral Sclerosis (P03.029) (2013) (0)
19. Placebo responses to AEDs (2010) (0)
[Computed tomography of the brain in dementia]. (1985) (0)
Sternocleidomastoid and trapezius dissociation (1989) (0)
Is there horizontal transmission of Creutzfeldt-Jakob disease? (2023) (0)
Lost in space(s): multimodal neuroimaging of disorientation along the Alzheimer’s disease continuum (2023) (0)
142. Occurrence of fatigue over 20years after apparent recovery from Guillain–Barré syndrome (2012) (0)
International Congress on Vascular Dementia, Athens, Greece, 17–20 October 2013 (2014) (0)
[Computed tomography of the brain--1987]. (1987) (0)
1-29-03 The gene for oculopharyngeal muscular dystrophy in a cluster of Bukhara Jews living in Israel also maps to chromosome 14q11.2-q13 (1997) (0)
Pseudo‐anticipation in Creutzfeldt–Jakob disease is due to a rhomboid‐shaped artifact (2019) (0)
A critical review of the prion hypothesis of human synucleinopathies (2017) (0)
Focus Group Abstracts (2005) (0)
Torsion dystonis (1988) (0)
Can Biomarkers Help the Early Diagnosis of Parkinson’s Disease? (2017) (0)
IN30-TU-03 Evidence-based or evidence-biased medicine (2009) (0)
Announcements (1961) (0)
Calendar (1989) (0)
[Stroke in hospitalized patients]. (1986) (0)
Upcoming Meetings Related to Alzheimer's Disease. (2016) (0)
Rating scales for dementia (1989) (0)
Reply to Possible Duplicate Publication (2002) (0)
Letters to the editor (1996) (0)
Sphenoidal EEG recording in complex partial seizures. (1986) (0)
Familial CJD with the E200k Mutation: Conversion and Onset of Disease (2014) (0)
Identification of a novel brain autoantigen, histidine rich glycoprotein (HRGP) (1997) (0)
Sympathetic pupillary activity in Jewish ethnic groups. (1979) (0)
Dementia: Evidence-Based Medicine and Epidemiological Update (2009) (0)
Nerve plasticity and aberrant regeneration. (1987) (0)
sclerosis syndrome : differential diagnosis from multiple Evoked potential studies in the antiphospholipid (2005) (0)
Dementia in non-SLE patients with lupus anticoagulant (1991) (0)
Click lateralization by multiple sclerosis patients (1988) (0)
[The central regulation of respiration]. (1969) (0)
The Israel society for EEG and clinical neurophysiology, annual meeting: Jerusalem, 12 November 1991 (1992) (0)
[Comparison of bioavailability of pilocarpine]. (1980) (0)
EEG findings with lose dose clozapine treatment in psychotic parkinsonian patients (1995) (0)
Upcoming Meetings Related to Alzheimer's Disease. (2015) (0)
International meeting calendar 1999 (2004) (0)
Genetic linkage studies of Alzheimer's disease in Israeli arabs (2000) (0)
Osmotic fragility of erythrocytes in myopathies (2004) (0)
Editorial comments (2011) (0)
[The use of combined analgesics]. (1978) (0)
Forthcoming meetings (2001) (0)
Epilepsy with Early Ataxia (2015) (0)
Vascular risk factors in Alzheimer's disease: The lesson learned (2009) (0)
Reply (1990) (0)
Effect of brain stem transections on the respiratory response to medullary stimulation. (1967) (0)
Does stress precipitate attacks of multiple sclerosis? (1991) (0)
[Myelopathy following clioquinol]. (1977) (0)
P3.018 Factors affecting time to levodopa-induced dyskinesias (2009) (0)
[Pyramidal signs]. (1978) (0)
Painful paroxysmal dystonia associated with focal epileptic activity. (1995) (0)
Increased Thromboxane B(2) Generation and β-Thromboglobulin Release from Activated Platelets in Myotonic Dystrophy. (1993) (0)
Computer mouse motion analysis in computerized screening tests for dementia: Interaction design and analysis (2005) (0)
Abstract TMP28: Serotonin Transporter Polymorphism Impact on Cortisol Level and Outcome After Stroke (2020) (0)
The correlation between antigenic specificity of antiphospholipid antibodies and neurological disease (1991) (0)
Arrhythmogenic effects of catechol- and sympathomimetic amines. Involvement of alpha and beta adrenoceptors (1990) (0)
Tolerance to the mydriatic effect of buprenorphine, butorphanol, nalbuphine, and cyclorphan, and cross-tolerance to morphine in mice (1994) (0)
Interaction of promethazine with neuroleptic drugs. (1979) (0)
CONy: a new perspective for readers of JNT (2011) (0)
Anti-cyclic citrullinated peptide antibody in accompany with vascular cell adhesion molecule 1(vcam-1): From preclinical to clinical approach to Parkinson's disease with dementia (2019) (0)
Thymectomy for myasthenia gravis. (1972) (0)
Other Dopamine Agonists (2002) (0)
I.8 Autonomic and sexual dysfunction in movement disorders (2006) (0)
Abstract TP460: Dominant Imaging Markers for Post Stroke Cognitive Performance in the TABASCO Study (2016) (0)
Introduction (2007) (0)
Is Donepezil Beneficial for Patients with Vascular Dementia (2004) (0)
3.057 MOVEMENT DISORDERS ARE PREVALENT IN PATIENTS WITH FAMILIAL CREUTZFELDT-JAKOB DISEASE (F-CJD) CARRYING THE E200K MUTATION (2012) (0)
[Alzheimer's disease]. (1984) (0)
Bell's palsy with monoclonal gammopathy (1973) (0)
Medical Cannabis for Gilles de la Tourette Syndrome: An Open-Label Prospective Study (2022) (0)
P1-092 Human-computer interaction in the administration and analysis of neuropsychological tests — A follow-up study (2004) (0)
Peptide neurotransmitters and their implications for the treatment of tardive dyskinesia. (1983) (0)
3.049 LEVODOPA-INDUCED DYSKINESIA IN PARKINSON'S DISEASE PATIENTS CARRYING THE LEUCINE-RICH REPEAT KINASE 2 (LRRK2) G2019S MUTATION (2012) (0)
Calendar (2009) (0)
Participation of epileptic patients in sports. (1979) (0)
Reply from the Author (1996) (0)
Recall of Ytzhak Rabin’s Assassination by Demented People (1998) (0)
058 DISORDERS OF GAIT WITH FEAR OF FALL IN COMMUNITY DWELLING ELDERS (2010) (0)
P-103 Therapy follow up in mild dementia subjects (2007) (0)
2-21-12 Headache following meningitis (1997) (0)
Contents Vol. 9, 1999 (1999) (0)
Phenytoin and folate deficiency: Failure to show dose dependency (1974) (0)
In memoriam Hans Sautter (1985) (0)
Can Hippocampal Size Predict Cognitive Impairment in Post-Stroke Patients? (2011) (0)
Binaural lateralization and discrimination in MS and CVA patients (1995) (0)
Subject Index Vol. 10, 1999 (1999) (0)
Abstract 47: Renal Function, MRI Brain Changes and Post-stroke Cognitive Impairment (2015) (0)
Ventilatory response to carbon dioxide in multiple sclerosis (1977) (0)
Epidemiology of senile dementia: Protective effect of education (1992) (0)
Forthcoming Meetings (2001) (0)
Aetiology of Bell's palsy. (1971) (0)
MECHANICAL VENTILATION. AUTHORS' REPLY (1997) (0)
[Teratogenic effects of anticonvulsants]. (1976) (0)
Is depression a new risk factor for dementia? (2009) (0)
[Breakthrough in Creutzfeldt-Jakob disease]. (1991) (0)
The Interrelation Between Chronic Headache, Cognitive Scores, and MRI Markers Among Stroke Survivors. (2021) (0)
Clinical aspects and noninvasive diagnostic approaches (1986) (0)
Sequence Variants in SLC6A3, DRD2, and BDNF Genes and Time to Levodopa-Induced Dyskinesias in Parkinson’s Disease (2014) (0)
In Memoriam: Milton Alter, MD, PhD (1929-2016). (2016) (0)
Abstracts Second Congress of the European Society for Clinical Neuropharmacology (1995) (0)
Diaphragmatic paralysis. (1977) (0)
Announcements (1962) (0)
Mechanical ventilation (1997) (0)
4-12-02 T P d (1997) (0)
LAY PERSONS ́ BELIEFS AND KNOWLEDGE ABOUT ALZHEIMER ́S AND PARKINSON ́S DISEASE (2011) (0)
Torsion dystonia. (1988) (0)
Amyloid reducing therapies: do they still have a future? (2016) (0)
The Beneficial Effect of Lisuride Hydrogen Maleate in the Long Term Treatment of Parkinson’s Disease (1990) (0)
Sex ratio in extrauterine pregnancies. (1974) (0)
Ariel Sharon's illness. (2008) (0)
[Neurochemical abnormalities in Huntington's disease]. (1983) (0)
Freezing of Gait Questionnaire--Self Administered Version (2014) (0)
Israeli Society for EEG and Clinical Neurophysiology. Jerusalem, 20 September, 1985. Abstracts. (1987) (0)
[Neuropeptides and neurotransmitters and their function in pain transmission]. (1981) (0)
Effect of pilocarpine in ocular hypotension. (1985) (0)
3.12.1 WHAT ARE THE PITFALLS OF CLINICAL TRIALS IN PARKINSON'S DISEASE? (2012) (0)
EEG findings may serve as a diagnostic aid in acetazolamide responsive periodic ataxia (ARPA) (1995) (0)
Announcement (1961) (0)
Transient neurogenic urinary retention. (1976) (0)
[The late Professor Bernard Bornstein]. (1977) (0)
Epilepsy genetics in Israeli and Palestinian Arabs (2005) (0)
Antibodies to a 200 kDa cholinergic antigen in Alzheimer's disease (1988) (0)
Israeli Society for EEG and clinical neurophysiology: Jerusalem, 6 May 1987 (1988) (0)
The neglected targets in AD prevention and treatment (2014) (0)
[Hypophyseal hormones--neurotransmitters?]. (1980) (0)
Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease--a beefy problem? (1996) (0)
P1-369 TRANSCRANIAL MAGNETIC STIMULATION OF DEEP BRAIN REGIONS IN ALZHEIMER’S DISEASE (2014) (0)
Combined Use of Neuroleptic Drugs (1977) (0)
[Temporary loss of consciousness]. (1977) (0)
Creutzfeldt-Jakob Disease (CJD) is Not an Infectious Disease (1995) (0)
Duration and factors affecting electroencephalogram slowing after generalized tonic-clonic seizures (1995) (0)
Quantitative analysis of phenotypic elements augments traditional electroclinical classification of common familial epilepsies (2019) (0)
Mechanism of epidural morphine analgesia (1987) (0)
Sick patient, normal tests. (2010) (0)
Israel society for EEG and clinical neurophysiology, 14th world congress of the Israel medical association: Jerusalem, 16–19 May 1988 (1989) (0)
Response of serum muscle enzymes to hydrocortisone in patients with myopathy. (1977) (0)
2nd World Congress on Controversies in Neurology (2009) (0)
PS-49-8 Muscle pseudohypertrophy in a patient with distal myopathy and rimmed vacuoles (1995) (0)
Efficacyof memantine, an NMDA receptor antagonist, in the treatment of Parkinson's disease (1992) (0)
P4-384 Apparent efficacy and reasons of discontinuation of cholinesterase inhibitors in Alzheimer’s disease (2006) (0)
[Memory: mechanisms and pathophysiology]. (1983) (0)
JNT Special Issue MDPD Congress, Berlin 2012 (2013) (0)
Cystotonometric Studies in Patients with Myelopathy (1976) (0)
Cholesterol and uric acid levels in patients with bell's palsy (2004) (0)
[Treatment of Parkinson's disease with COMT inhibitors]. (2001) (0)
Chapter 9 GM(2) gangliosidoses. (2007) (0)
Management of Mild Cognitive Impairment (2020) (0)
Reply (1981) (0)
P1-066 Human-computer interaction in the administration and analysis of neuropsychological tests (2004) (0)
Bell's palsy and diabetes mellitus. (1971) (0)
Front & Back Matter (2021) (0)
Audiological Findings in Patients with Bell's Palsy (1972) (0)
Cognitive and behavioral changes in Parkinson complex (2009) (0)
[Nobel prize winners in medicine--1981 (Torsten Wiesel, David Hubel)]. (1981) (0)
Unilateral thermal anaesthesia (1986) (0)
Current conceptions of the etiology and risk factors for Alzheimer's disease and their possible implications on the design of dementia clinical trials (2011) (0)
Poster Session‐Saturday (2016) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Amos D. Korczyn?

Amos D. Korczyn is affiliated with the following schools:

Tel Aviv University

Amos D. Korczyn's Academic­Influence.com Rankings

Amos D. Korczyn's Degrees

Why Is Amos D. Korczyn Influential?

Amos D. Korczyn's Published Works

Published Works

What Schools Are Affiliated With Amos D. Korczyn?

Amos D. Korczyn's AcademicInfluence.com Rankings